Bimatoprost (CAS 155206-00-1) is a prostamide / prostaglandin analog used primarily to treat elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, thereby lowering intraocular pressure and helping to prevent optic nerve damage and vision loss.
Clinically, Bimatoprost is well known not only for its ocular efficacy but also for the eyelash-growth effect observed as a cosmetic side benefit in many patients. This has led to its use in specialized formulations aimed at enhancing eyelash length, thickness and darkness under medical supervision.
At TCS GROUP, Bimatoprost 155206-00-1 is offered as a high-purity ophthalmic API with robust quality control and GMP-oriented manufacturing. Detailed technical data, impurity profiles and documentation (including DMF/CTD support where applicable) are available to streamline registration and regulatory submissions in multiple markets.
From a formulation standpoint, Bimatoprost is typically incorporated into sterile ophthalmic solutions at very low concentrations. Developers must pay close attention to pH, tonicity, buffering systems and preservative choice to ensure comfort, stability and microbiological safety of the eye drops. Packaging selection (e.g. multi-dose bottles vs single-use vials) also plays a significant role in product performance and shelf life.
Because Bimatoprost sits within a broader cardiovascular-ocular and chronic-care portfolio, many partners source complementary APIs from TCS GROUP to simplify procurement. Within the Active Pharmaceutical Ingredient range presented on the company’s Active Pharmaceutical Ingredient overview page, you can also find related cardiovascular actives like Atenolol 29122-68-7, a cardioselective beta-blocker for hypertension, and Benazepril 86541-75-5, an ACE inhibitor widely used in antihypertensive therapy.
Working with TCS INDUSTRIES LIMITED for Bimatoprost supply means gaining a long-term partner that understands both the technical complexity and regulatory expectations in the ophthalmic space. Consistent quality, reliable lead times and technical support help generic manufacturers and brand owners build or expand their glaucoma and eyelash-enhancement portfolios with confidence.